Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

NeuroOp Guru

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

All Videos

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

Videos

Mah previews a packed 2025 Annual Meeting, from the debut of SightLine to Dr. Glaucomflecken’s return to the main stage, and outlines his priorities for the year ahead as incoming ASCRS president.

Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy

Articles

This agreement allows a launch in the US in the second half of 2026 or earlier in certain circumstances.

Biocon achieves settlement agreement with Regeneron to launch aflibercept biosimilar, Yesafili in the US

Sheryl brings a wealth of editorial experience to MJH Life Sciences’ Eye Care Network, having engaged with the readers and the greater ophthalmic community of 

for more than 20 years. As Group Editorial Director, Sheryl’s purview extends across the print and digital network of 

Ophthalmology Times, Ophthalmology Times Europe, Modern Retina 

 Prior to ophthalmology, Sheryl previously covered the fields of audiology and confectionery science/technology/manufacturing.

Sheryl is also passionate about the mission, vision and values of Ophthalmic World Leaders (OWL) and recently completed her term on its Board of Directors. She continues to volunteer as Editor-in-Chief of the organization’s 

Magazine. In 2013, she was honored with the group’s inaugural Rising Star Award.

In addition, she has served as a judge for 

 Health Care Heroes Awards program as well as the Jesse H. Neal National Business Journalism Awards.

Piecing it together: Does semaglutide fit the NAION puzzle?

Eyecyte-RPE is a suspension of human induced Pluripotent Stem Cells derived retinal pigment epithelial cells. 

Eyestem releases positive results from phase 1 trial in patients with geographic atrophy

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

About

Advertise

Privacy

Editorial Info

Editorial Board

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

View

Bridging the Gap in Dry Eye Management with Targeted Interventions  

Cyclosporine Ophthalmic Solution for Inflammatory Dry Eye

Video content above is prompted by the following question(s):

1. Cyclosporine ophthalmic solution, 0.1% (VEVYE)

Alice Epitropoulos, MD, and Laura M. Periman, MD, discuss comprehensive dry eye diagnosis.and management, covering key diagnostic tests, new therapies, and future advancements.

Alice Epitropoulos, MD, and Laura M. Periman, MD, share insights on the various diagnostic tests they employ for patients exhibiting dry eye symptoms. 

Key Diagnostic Tests for Dry Eye Evaluation

Dry eye experts discuss tear film assessment techniques and emphasize the importance of distinguishing between aqueous-deficient and evaporative dry eye for targeted treatment approaches.

Assessing Tear Film Abnormalities

Dry eye experts discuss how they use a comprehensive dry eye diagnostic approach to tailor and customize individual patients. 

Need for a Proactive Approach to Dry Eye Evaluation

Evolving Treatment Strategies for Dry Eye

Dry eye experts discuss how they tailor dry eye treatment based on diagnostic test results and other factors. 

Treating Inflammation and Evaporative Dry Eye

Perfluorohexyloctane Ophthalmic Solution for Evaporative Dry Eye

Dry eye experts discuss Cyclosporine ophthalmic solution.

Dry eye experts discuss the future of dry eye management. 

Future of Dry Eye Management

Our disease focused Insights discussion feature Key Opinion Leaders (KOLs) and industry experts on topics that range from diagnosis and treatment to the patient journey, genetic testing and beyond.

Cyclosporine Ophthalmic Solution for Inflammatory Dry Eye

EP: 1.Key Diagnostic Tests for Dry Eye Evaluation

EP: 2.Assessing Tear Film Abnormalities

EP: 3.Need for a Proactive Approach to Dry Eye Evaluation

EP: 4.Evolving Treatment Strategies for Dry Eye

EP: 5.Treating Inflammation and Evaporative Dry Eye

EP: 6.Perfluorohexyloctane Ophthalmic Solution for Evaporative Dry Eye

EP: 7.Cyclosporine Ophthalmic Solution for Inflammatory Dry Eye

EP: 8.Future of Dry Eye Management

Newsletter